Arcus Biosciences Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| GILEAD SCIENCES, INC. | 08/03/2026 | 31.42 M | $968.83 M | 0.00% | 24.92% |
| BLACKROCK, INC. | 08/07/2026 | 16.42 M | $506.11 M | 7.81% | 13.02% |
| STATE STREET CORP | 08/07/2026 | 6.03 M | $185.89 M | 11.39% | 4.78% |
| WELLINGTON MANAGEMENT GROUP LLP | 08/14/2026 | 5.90 M | $181.76 M | -3.19% | 4.68% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 08/14/2026 | 4.78 M | $147.26 M | -5.06% | 3.79% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 08/13/2026 | 4.48 M | $137.98 M | 4.76% | 3.55% |
| FMR LLC | 08/13/2026 | 4.05 M | $124.85 M | 247.54% | 3.21% |
| VANGUARD CAPITAL MANAGEMENT LLC | 08/13/2026 | 3.89 M | $119.88 M | 0.82% | 3.08% |
| CITADEL ADVISORS LLC | 09/02/2026 | 3.14 M | $96.65 M | 135.73% | 2.49% |
| WOODLINE PARTNERS LP | 08/14/2026 | 3.01 M | $92.73 M | -20.38% | 2.39% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/12/2026 | 2.45 M | $75.51 M | 8.72% | 1.94% |
| SIREN, L.L.C. | 08/13/2026 | 2.42 M | $74.62 M | -19.51% | 1.92% |
| FISHER ASSET MANAGEMENT, LLC | 08/04/2026 | 2.14 M | $65.96 M | -2.33% | 1.70% |
| MARSHALL WACE, LLP | 08/13/2026 | 1.95 M | $59.97 M | -48.29% | 1.54% |
| SAMLYN CAPITAL, LLC | 08/14/2026 | 1.55 M | $47.70 M | -18.93% | 1.23% |
| DIMENSIONAL FUND ADVISORS LP | 08/11/2026 | 1.43 M | $44.22 M | 0.57% | 1.14% |
| BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. | 08/13/2026 | 1.42 M | $43.76 M | -14.21% | 1.13% |
| GOLDMAN SACHS GROUP INC | 08/14/2026 | 1.39 M | $42.78 M | 38.79% | 1.10% |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 08/11/2026 | 1.17 M | $36.03 M | 158.58% | 0.93% |
| SOFINNOVA INVESTMENTS, INC. | 08/14/2026 | 945.69 K | $29.16 M | 2.45% | 0.75% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/14/2026 | 941.76 K | $29.03 M | 4.22% | 0.75% |
| SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. | 08/14/2026 | 941.76 K | $29.03 M | 100.00% | 0.75% |
| NORTHERN TRUST CORP | 08/13/2026 | 932.52 K | $28.75 M | 10.97% | 0.74% |
| PARKMAN HEALTHCARE PARTNERS LLC | 08/14/2026 | 919.27 K | $28.34 M | -23.86% | 0.73% |
| INVESCO LTD. | 08/14/2026 | 845.23 K | $26.06 M | 2.97% | 0.67% |
| BAKER BROS. ADVISORS LP | 08/14/2026 | 844.82 K | $26.05 M | 103.27% | 0.67% |
| BANK OF AMERICA CORP /DE/ | 08/14/2026 | 835.50 K | $25.76 M | 29.32% | 0.66% |
| MORGAN STANLEY | 08/13/2026 | 795.91 K | $24.54 M | -28.52% | 0.63% |
| CANDRIAM S.C.A. | 08/13/2026 | 661.98 K | $20.39 M | -16.27% | 0.53% |
| ABRDN PLC | 07/31/2026 | 650.71 K | $20.06 M | -15.47% | 0.52% |
| LOGOS GLOBAL MANAGEMENT LP | 08/14/2026 | 650.00 K | $20.04 M | -45.83% | 0.52% |
| TWO SIGMA INVESTMENTS, LP | 08/14/2026 | 635.40 K | $19.59 M | 103.21% | 0.50% |
| VANGUARD FIDUCIARY TRUST CO | 08/13/2026 | 616.09 K | $18.99 M | 5.69% | 0.49% |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 08/14/2026 | 589.55 K | $18.18 M | 100.00% | 0.47% |
| BANK OF NEW YORK MELLON CORP | 08/06/2026 | 543.01 K | $16.74 M | 6.23% | 0.43% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 08/14/2026 | 512.08 K | $15.79 M | 18.99% | 0.41% |
| IKARIAN CAPITAL, LLC | 08/14/2026 | 504.56 K | $15.56 M | 100.00% | 0.40% |
| DECHENG CAPITAL LLC | 08/14/2026 | 464.78 K | $14.33 M | -2.73% | 0.37% |
| DAFNA CAPITAL MANAGEMENT LLC | 08/14/2026 | 441.83 K | $13.62 M | -0.45% | 0.35% |
| PRINCIPAL FINANCIAL GROUP INC | 08/04/2026 | 423.37 K | $13.05 M | 2.32% | 0.34% |
| JPMORGAN CHASE & CO | 08/12/2026 | 418.24 K | $13.12 M | 417.52% | 0.33% |
| MACQUARIE MANAGEMENT HOLDINGS, INC. | 08/14/2026 | 379.10 K | $11.69 M | 0.00% | 0.30% |
| UBS GROUP AG | 08/13/2026 | 369.06 K | $11.38 M | 27.76% | 0.29% |
| PATIENT SQUARE CAPITAL LP | 08/12/2026 | 355.80 K | $10.97 M | 82.46% | 0.28% |
| PDT PARTNERS, LLC | 08/14/2026 | 323.57 K | $9.98 M | -16.68% | 0.26% |
| PUBLIC SECTOR PENSION INVESTMENT BOARD | 08/13/2026 | 298.16 K | $9.19 M | -1.70% | 0.24% |
| FIRST TRUST ADVISORS LP | 08/11/2026 | 271.43 K | $8.37 M | 1,972.33% | 0.22% |
| NUVEEN, LLC | 08/11/2026 | 234.05 K | $7.22 M | 5.57% | 0.19% |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 08/13/2026 | 225.01 K | $6.94 M | -20.12% | 0.18% |
| DIADEMA PARTNERS LP | 08/14/2026 | 223.81 K | $6.90 M | -6.02% | 0.18% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Arcus Biosciences Inc institutional Ownership - FAQ's
During the previous two years, 300 institutional investors and hedge funds held shares of Arcus Biosciences Inc. The most heavily invested institutionals were:
GILEAD SCIENCES, INC.: 31.42 M
BlackRock, Inc.: 16.42 M
STATE STREET CORP: 6.03 M
WELLINGTON MANAGEMENT GROUP LLP: 5.9 M
SUVRETTA CAPITAL MANAGEMENT, LLC: 4.78 M
VANGUARD PORTFOLIO MANAGEMENT LLC: 4.48 M
98.03% of Arcus Biosciences Inc stock is owned by institutional investors.
Institutional investors have bought a total of 148.09 M shares in the last 24 months. This purchase volume represents approximately $3.47 B in transactions.